文献速递生殖医学

COMPI生育问题压力量表是评估寻求治疗患者压力的简短、有效且可靠的工具

COMPI Fertility Problem Stress Scales is a brief, valid and reliable tool for assessing stress in patients seeking treatment.
PubMed 文献 · Hum Reprod · 2016-12-15

本研究为横断面研究,在丹麦、中国、克罗地亚、德国、希腊、匈牙利和瑞典七国临床机构招募3923例生育患者(1691例男性、2232例女性),检验COMPI生育问题压力量表(COMPI-FPSS)的信效度与测量不变性。结果确认原三因子结构,缩短版模型拟合更优;多数国家数据拟合良好,性别间完全不变,文化间部分不变。

要点

  • COMPI-FPSS在多数分析国家呈现优异或良好拟合,支持其作为简短压力评估工具。
  • 量表在性别间达到完全测量不变性,在文化间为部分不变性。
  • 中国和克罗地亚子样本数据未达良好拟合。

核心结论

  • COMPI-FPSS是有效且可靠的测量工具,在多数分析国家呈现优异或良好拟合,并展示性别间完全不变和文化间部分不变。

研究设计与样本

  • 横断面研究,最终样本为3923例生育患者(1691例男性、2232例女性),来自丹麦、中国、克罗地亚、德国、希腊、匈牙利和瑞典七国临床机构,平均年龄34岁,84%无子女。

主要发现

  • 确认COMPI-FPSS原三因子结构,但提示采用更少条目的缩短测量模型比完整版模型拟合数据更好。
  • 中国和克罗地亚子样本数据未拟合,其他所有国家呈现良好拟合(χ2/df ≤ 5.4;比较拟合指数 ≥ 0.94;近似误差均方根 ≤ 0.07;修正期望交叉验证指数 ≤ 0.77)。
  • 各国家所有子量表一般观察到信度、收敛效度和区分效度(组合信度 ≥ 0.63;平均方差提取 ≥ 0.38; squared correlation ≥ 0.13)。
  • 性别间建立完全不变性,国家间展示部分不变性。

关键数值与推荐

  • 良好拟合标准:χ2/df ≤ 5.4;比较拟合指数 ≥ 0.94;近似误差均方根 ≤ 0.07;修正期望交叉验证指数 ≤ 0.77。
  • 信效度标准:组合信度 ≥ 0.63;平均方差提取 ≥ 0.38; squared correlation ≥ 0.13。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 关于COMPI-FPSS验证的普遍性不能推广至未寻求治疗的不孕个体或非欧洲患者。
  • 本研究未调查预测效度,因此该工具检测生育特异性适应随时间变化的能力和预测心理影响的能力需在未來研究中建立。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Are the Copenhagen Multi-Centre Psychosocial Infertility research program Fertility Problem Stress Scales (COMPI-FPSS) a reliable and valid measure across gender and culture? SUMMARY ANSWER: The COMPI-FPSS is a valid and reliable measure, presenting excellent or good fit in the majority of the analyzed countries, and demonstrating full invariance across genders and partial invariance across cultures. WHAT IS KNOWN ALREADY: Cross-cultural and gender validation is needed to consider a measure as standard care within fertility. The present study is the first attempting to establish comparability of fertility-related stress across genders and countries. STUDY DESIGN SIZE, DURATION: Cross-sectional study. First, we tested the structure of the COMPI-FPSS. Then, reliability and validity (convergent and discriminant) were examined for the final model. Finally, measurement invariance both across genders and cultures was tested. PARTICIPANTS/MATERIALS, SETTING, METHODS: Our final sample had 3923 fertility patients (1691 men and 2232 women) recruited in clinical settings from seven different countries: Denmark, China, Croatia, Germany, Greece, Hungary and Sweden. Participants had a mean age of 34 years and the majority (84%) were childless. MAIN RESULTS AND THE ROLE OF CHANCE: Findings confirmed the original three-factor structure of the COMPI-FPSS, although suggesting a shortened measurement model using less items that fitted the data better than the full version model. While data from the Chinese and Croatian subsamples did not fit, all other counties presented good fit (χ2/df ≤ 5.4; comparative fit index ≥ 0.94; root-mean-square error of approximation ≤ 0.07; modified expected cross-validation index ≤ 0.77). In general, reliability, convergent validity, and discriminant validity were observed in all subscales from each country (composite reliability ≥ 0.63; average variance extracted ≥ 0.38; squared correlation ≥ 0.13). Full invariance was established across genders, and partial invariance was demonstrated across countries. LIMITATIONS REASONS FOR CAUTION: Generalizability regarding the validation of the COMPI-FPSS cannot be made regarding infertile individuals not seeking treatment, or non-European patients. This study did not investigate predictive validity, and hence the capability of this instrument in detecting changes in fertility-specific adjustment over time and predicting the psychological impact needs to be established in future research. WIDER IMPLICATIONS OF THE FINDINGS: Besides extending knowledge on the psychometric properties of one of the most used fertility stress questionnaire, this study demonstrates both research and clinical usefulness of the COMPI-FPSS. STUDY FUNDING/COMPETING INTERESTS: This study was supported by European Union Funds (FEDER/COMPETE-Operational Competitiveness Program, and by national funds (FCT-Portuguese Foundation for Science and Technology) under the projects PTDC/MHC-PSC/4195/2012 and SFRH/BPD/85789/2012). There are no conflicts of interest to declare. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Sobral MP, Costa ME, Schmidt L, et al. COMPI Fertility Problem Stress Scales is a brief, valid and reliable tool for assessing stress in patients seeking treatment. Hum Reprod. 2016. PMID: 27979919. doi:10.1093/humrep/dew315

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。